Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on Jun 29, 2015
EDEN PRAIRIE, Minn., June 29, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today that it has exercised the right to borrow an additional $2 million under its existing loan and security agreement with Silicon Valley Bank. The right to borrow this second tranche was conditioned...

Read More

Posted on May 26, 2015
EDEN PRAIRIE, Minn., May 26, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) is pleased to announce that the US Food and Drug Administration (FDA) has approved the resumption of patient enrollment in its COUNTER HF US pivotal study for the C-Pulse Heart Assist System. As such, the Company...

Read More

Posted on May 5, 2015
EDEN PRAIRIE, Minn., May 5, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today its financial results and provided a corporate update for the first quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and pro...

Read More

Events & Presentations